Yoshimasa Ishizaki

7PUBLICATIONS
23CO-AUTHORS
Infectious agentsBiologically active moleculesMedical infection agents (incl. prions)Peripheral nervous systemMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 30, 2026
Antimicrobial peptides derived from Nemuri induce ribosomal condensation to inhibit translation.

|Sep 29, 2026
Amino acid mapping-guided scaffold selection and hit identification of histidine kinase inhibitors from a virtual library of over 12 million compounds.

|Nov 22, 2025
Thiofrenomycins, new kalafungin-type pyranonaphthoquinone skeleton with sulfide linkage from Streptomyces sp. MM863L-181F9.

Tomoyuki Kimura, Yoshimasa Ishizaki, Maya Umekita

|Dec 16, 2024
Novobiocin primarily targets ParE in Neisseria gonorrhoeae.

Yoshimasa Ishizaki, Chigusa Hayashi, Kazuaki Matoba

|Oct 29, 2024
Thiazoplanomicin, a new thiazolyl peptide antibiotic from the leaf-litter actinomycete Actinoplanes sp. MM794L-181F6.

Yasuhiro Takehana, Hideyuki Muramatsu, Masaki Hatano

|Sep 27, 2023
Cycloimidamicins, Novel natural lead compounds for translation inhibition in Pseudomonas aeruginosa.

Yoshimasa Ishizaki, Maya Umekita, Rie Arisaka

Pageof 2

Frequent Collaborators

6 joint publications

Masayuki Igarashi

3 joint publications

Ryuichi Sawa

2 joint publications

Hideyuki Muramatsu

2 joint publications

Toshihide Okajima